Abstract |
Central histaminergic modulation of H1 rather than H2-receptors has been shown to modify epileptic activity. Compounds acting on the HIC- and H3-receptors were tested against chemically-induced seizures in mice. Compounds antagonising the microsomal and nuclear intracellular receptors (HIC) only modified seizures at doses where toxicity was observed. Antagonists of the histamine H3-receptor ( thioperamide and burimamide) only potentiated the severity of clonic convulsions induced by picrotoxin, while impromidine (i.c.v.), an antagonist with H2-agonist activity, inhibited leptazol-induced seizures. The H3-agonist, (R) alpha-methylhistamine, potentiated chemically-induced seizures, but at lower doses there was slight inhibition.
|
Authors | G Sturman, P Freeman, H M Meade, N A Seeley |
Journal | Agents and actions
(Agents Actions)
Vol. 41 Spec No
Pg. C68-9
(Jun 1994)
ISSN: 0065-4299 [Print] Switzerland |
PMID | 7976808
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anticonvulsants
- Convulsants
- Histamine Agonists
- Histamine Antagonists
- Histamine H1 Antagonists
- Receptors, Histamine H3
- Picrotoxin
- Pentylenetetrazole
|
Topics |
- Animals
- Anticonvulsants
(pharmacology)
- Behavior, Animal
(drug effects)
- Convulsants
(pharmacology)
- Histamine Agonists
- Histamine Antagonists
- Histamine H1 Antagonists
(pharmacology)
- Male
- Mice
- Mice, Neurologic Mutants
- Pentylenetetrazole
- Picrotoxin
- Receptors, Histamine H3
(physiology)
- Seizures
(chemically induced)
|